What's in King Saud Medical City's pipeline?

King Saud Medical City has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with King Saud Medical City's portfolio?

Top competitors by shared drug class: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Hospitales Universitarios Virgen del Rocío, Mahmoud I Mostafa, Merck Sharp & Dohme LLC, Vanderbilt University Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/king-saud-medical-city.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

King Saud Medical City — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

King Saud Medical City pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Standard Dose Colistin	Standard Dose Colistin	marketed	Polymyxin antibiotic	Bacterial lipopolysaccharides and phospholipids	Infectious Disease
High Dose Colistin	High Dose Colistin	marketed	Polymyxin antibiotic	Bacterial lipopolysaccharide (LPS) and outer membrane	Infectious Disease

Therapeutic area mix

Infectious Disease · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 shared drug class
Hospitales Universitarios Virgen del Rocío · 1 shared drug class
Mahmoud I Mostafa · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
Vanderbilt University Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for King Saud Medical City:

Cite this brief

Drug Landscape (2026). King Saud Medical City — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/king-saud-medical-city. Accessed 2026-05-16.